Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Amgen Inc.
  6. News
  7. Summary
    AMGN   US0311621009

AMGEN INC.

(AMGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about AMGEN INC.
10/12AMGEN : Morgan Stanley Adjusts Amgen PT $235 from $251, Keeps Equalweight Rating
MT
10/11AMGEN : Working Together to Improve Public Health Outcomes
PU
10/08AMGEN : Discover What Fosters Innovation and Drives Change Through Amgen's Innovation2 Ser..
PU
10/07AMGEN : Announces New LUMAKRAS™ (sotorasib) Combination Data From Phase 1b CodeBreaK..
PR
10/07Amgen Announces New LUMAKRASÖ Combination Data From Phase 1b CodeBreaK 101 Study In Pat..
CI
10/07AMGEN : Working With Neumora Therapeutics to Develop Therapeutics for Brain Diseases
MT
10/07AMGEN : and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel ..
PR
10/07Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel..
CI
10/07Neumora announced that it has received $500 million in funding from a group of investor..
CI
10/05Amgen's 'Underappreciated' Inflammation Portfolio Set to Trigger Growth, RBC Capital An..
MT
10/04AMGEN : Presentation on Inflammation Portfolio from EADV
PU
10/02Kyowa Kirin and Amgen Present Positive Late-Breaking Data from Phase 2 Study of KHK4083..
CI
10/01GLOBAL DIVERSITY AWARENESS MONTH : Our Differences Lead to Better Science
PU
09/29AMGEN : To Webcast Investor Call At EADV 2021
PR
09/28CANDID CONVERSATIONS : Amgen Latin Employee Network
PU
More most relevant news
All news about AMGEN INC.
10/15Analysis-Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
RE
10/15Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
RE
10/13LUYE PHARMA : Chinese Regulators Accept Luye Pharma's Marketing Authorization for Osteopor..
MT
10/12AMGEN : Morgan Stanley Adjusts Amgen PT $235 from $251, Keeps Equalweight Rating
MT
10/11AMGEN : Working Together to Improve Public Health Outcomes
PU
10/08ADRs Close Higher; Oil Majors Trade Actively
DJ
10/08AMGEN : Discover What Fosters Innovation and Drives Change Through Amgen's Innovation2 Ser..
PU
10/08ASTRAZENECA : Gets US FDA's Orphan Drug Designation for Eosinophilic Esophagitis Drug
MT
10/08ASTRAZENECA : Tezepelumab Gets FDA Orphan Designation for Eosinophilic Esophagitis
DJ
10/07AMGEN : Announces New LUMAKRAS™ (sotorasib) Combination Data From Phase 1b CodeBreaK..
PR
More news
News in other languages on AMGEN INC.
10/13Les autorités réglementaires chinoises acceptent l'autorisation de commercialisation de..
10/08AstraZeneca obtient de la FDA la désignation de médicament orphelin pour son médicament..
10/08ASTRAZENECA : désignation de médicament orphelin aux USA
10/05Selon l'analyste de RBC Capital, le portefeuille de l'inflammation " sous-estimé " d'Am..
09/27Amgen obtient l'autorisation de la FDA pour le Repatha dans l'hypercholestérolémie fami..
09/21Amgen obtient un jugement favorable dans un litige en matière de brevets contre Sandoz ..
09/16Amgen s'engage dans une collaboration avec Boehringer Ingelheim pour étudier une associ..
09/16Amgen affirme que l'association de médicaments contre le cancer colorectal est sûre et ..
09/10Wall Street : s'essouffle au final, mais repli sans intensité
09/09Wall Street : s'essouffle au final, mais repli sans intensité
More news
Analyst Recommendations on AMGEN INC.
10/12AMGEN : Morgan Stanley Adjusts Amgen PT $235 from $251, Keeps Equalweight Rating
MT
09/23AMGEN : Daiwa Securities Downgrades Amgen to Neutral From Outperform, Price Target at $220
MT
09/23ANALYST RECOMMENDATIONS : Amgen, Apple, AstraZeneca, FedEx, T-Mobile US...
09/07AMGEN : Morgan Stanley Downgrades Amgen to Equalweight from Overweight, Adjusts Price Targ..
MT
09/07ANALYST RECOMMENDATIONS : Amgen, Banner, Merck, Oracle, Phoenix...
More recommendations
Press releases
10/11AMGEN : Working Together to Improve Public Health Outcomes
PU
10/08AMGEN : Discover What Fosters Innovation and Drives Change Through Amgen's Innovation2 Ser..
PU
10/07AMGEN : Announces New LUMAKRAS™ (sotorasib) Combination Data From Phase 1b CodeBreaK..
PR
10/07AMGEN : and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel ..
PR
10/04AMGEN : Presentation on Inflammation Portfolio from EADV
PU
More press releases
Upcoming event on AMGEN INC.